Thompson Siegel & Walmsley’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-1,157
Closed -$21K – 799
2018
Q1
$21K Hold
1,157
– – ﹤0.01% 614
2017
Q4
$22K Hold
1,157
– – ﹤0.01% 642
2017
Q3
$20K Buy
+1,157
New +$19.3K ﹤0.01% 648

Other funds holding DIAX

Thompson Siegel & Walmsley's DIAX Position: Q2 2018 in Review

Thompson Siegel & Walmsley sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q2 2018, closing a stake of 1,157 shares — an estimated $21K sold.

Thompson Siegel & Walmsley first reported a position in DIAX in Q3 2017 and held it in 3 quarters. The position peaked at $22K in Q4 2017. 67 funds tracked by Wall St. Rank hold DIAX as of Q2 2018.

  • Thompson Siegel & Walmsley reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q2 2018 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 1,157 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q2 2018, an estimated $21K.
  • Thompson Siegel & Walmsley first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q3 2017 and held it in 3 quarters.
  • Thompson Siegel & Walmsley's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $22K in Q4 2017.
  • 67 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q2 2018.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2018, filed 9 Aug 2018.